相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications
Monika Haack et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans
Verity L. Chadwick et al.
CURRENT OPINION IN PSYCHIATRY (2020)
TRPV1 regulates inflammatory process in the tongue of surgically induced xerostomia mouse
Min H. Yoo et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Mechanical sensitivity and psychological factors in patients with burning mouth syndrome
Mika Honda et al.
CLINICAL ORAL INVESTIGATIONS (2019)
Proteomics of the acid-soluble fraction of whole and major gland saliva in burning mouth syndrome patients
Tiziana Cabras et al.
ARCHIVES OF ORAL BIOLOGY (2019)
Change in gray matter volume and cerebral blood flow in patients with burning mouth syndrome
Young Chan Lee et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2019)
Terpenes in Cannabis sativa - From plant genome to humans
Judith K. Booth et al.
PLANT SCIENCE (2019)
Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
Hong Sheng Cheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Association of somatosensory dysfunction with symptom duration in burning mouth syndrome
Kosuke Watanabe et al.
CLINICAL ORAL INVESTIGATIONS (2019)
Efficacy of ultramicronized palmitoylethanolamide in burning mouth syndrome-affected patients: a preliminary randomized double-blind controlled trial
Giulia Ottaviani et al.
CLINICAL ORAL INVESTIGATIONS (2019)
Efficacy of cannabinoids in paediatric epilepsy
Shayma Ali et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2019)
Burning mouth syndrome-a diagnostic dilemma
Richeal Ni Riordain et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2019)
Role of palmitoylethanolamide (PEA) in depression: Translational evidence Special Section on Translational and Neuroscience Studies in Affective Disorders. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders
Danilo De Gregorio et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review
Trang T. H. Tu et al.
BIOPSYCHOSOCIAL MEDICINE (2019)
Plasma IL-8 signature correlates with pain and depressive symptomatology in patients with burning mouth syndrome: Results from a pilot study
Alison Barry et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
A case-control evaluation of fungiform papillae density in burning mouth syndrome
Jason M. Naud et al.
LARYNGOSCOPE (2018)
Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling
Talita A. Vrechi et al.
NEUROTOXICITY RESEARCH (2018)
Burning mouth syndrome: a systematic review of treatments
Y. F. Liu et al.
ORAL DISEASES (2018)
Is burning mouth syndrome a neuropathic pain condition?
Satu K. Jaaskelainen
PAIN (2018)
Functional interrelationships between the kallikrein-related peptidases family and the classical kinin system in the human neutrophil
Pamela Ehrenfeld et al.
BIOLOGICAL CHEMISTRY (2018)
Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization
Molly Braun et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Treatment modalities for burning mouth syndrome: a systematic review
Isadora Follak de Souza et al.
CLINICAL ORAL INVESTIGATIONS (2018)
TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endo-cannabinoids and Nociceptive Signalling
Maksim V. Storozhuk et al.
CURRENT NEUROPHARMACOLOGY (2018)
Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems
William E. Fantegrossi et al.
DRUG METABOLISM REVIEWS (2018)
Comparison between burning mouth syndrome patients with and without psychological problems
M. -J. Kim et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2018)
The role of psychological factors in the development of burning mouth syndrome
H. S. Yoo et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2018)
Plasma N-acylethanolamine and endocannabinoid levels in burning mouth syndrome: Potential role in disease pathogenesis
Alison Barry et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects
Aitziber Mendiguren et al.
LIFE SCIENCES (2018)
Inhibition of mitochondrial permeability transition pore opening contributes to cannabinoid type 1 receptor agonist ACEA-induced neuroprotection
Lei Ma et al.
NEUROPHARMACOLOGY (2018)
Saliva on the oral mucosa and whole saliva in women diagnosed with burning mouth syndrome
Shikha Acharya et al.
ORAL DISEASES (2018)
The association between burning mouth syndrome and sleep disturbance: A case-control multicentre study
D. Adamo et al.
ORAL DISEASES (2018)
Changes in the vibration sensitivity and pressure pain thresholds in patients with burning mouth syndrome
Brenda de Souza Moura et al.
PLOS ONE (2018)
The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial
Jenny G. Turcott et al.
SUPPORTIVE CARE IN CANCER (2018)
Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer
Melissa E. Badowski et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
ANXIETY AND DEPRESSION SCORES IN PATIENTS WITH BURNING MOUTH SYNDROME
Miroslav Sikora et al.
PSYCHIATRIA DANUBINA (2018)
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Federica Pellati et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Clinical characterization of women with burning mouth syndrome in a case-control study
Shikha Acharya et al.
ACTA ODONTOLOGICA SCANDINAVICA (2018)
Burning Mouth Syndrome: A Comparative Cross-sectional Study
Maryam Rabiei et al.
CONTEMPORARY CLINICAL DENTISTRY (2018)
Analgesic effect of topical oral capsaicin gel in burning mouth syndrome
Mette Rose Jorgensen et al.
ACTA ODONTOLOGICA SCANDINAVICA (2017)
Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study
Yves Boucher et al.
CLINICAL ORAL INVESTIGATIONS (2017)
Opiorphin in burning mouth syndrome patients: a case-control study
Ivan Salaric et al.
CLINICAL ORAL INVESTIGATIONS (2017)
Polymorphisms of interleukin-1β and MUC7 genes in burning mouth syndrome
Moon-Jong Kim et al.
CLINICAL ORAL INVESTIGATIONS (2017)
Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome
Asta Tvarijonaviciute et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2017)
Cannabis cultivation: Methodological issues for obtaining medical-grade product
Suman Chandra et al.
EPILEPSY & BEHAVIOR (2017)
Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients
Sebastian Schimrigk et al.
EUROPEAN NEUROLOGY (2017)
Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome
Dimos D. Mitsikostas et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis
Pasquale Annunziata et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Burning mouth syndrome and associated factors: A case-control retrospective study
Eduardo Chimenos-Kuestner et al.
MEDICINA CLINICA (2017)
Potential protein biomarkers for burning mouth syndrome discovered by quantitative proteomics
Eoon Hye Ji et al.
MOLECULAR PAIN (2017)
Altered structural connectivity of pain-related brain network in burning mouth syndrome-investigation by graph analysis of probabilistic tractography
Akihiko Wada et al.
NEURORADIOLOGY (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Taste function assessed by electrogustometry in burning mouth syndrome: a case-control study
A. Braud et al.
ORAL DISEASES (2017)
Efficacy of low level laser therapy in the treatment of burning mouth syndrome: A systematic review
Sadeq Ali Al-Maweri et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2017)
Profiling intraoral neuropathic disturbances following lingual nerve injury and in burning mouth syndrome
Amely Hartmann et al.
BMC ORAL HEALTH (2017)
Is it Sjogren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms
Hawra Aljanobi et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2017)
Functional alterations of Postcentral gyrus Modulated by angry Facial expressions during intraoral Tactile stimuli in Patients with Burning Mouth syndrome: a Functional Magnetic resonance imaging study
Atsuo Yoshino et al.
FRONTIERS IN PSYCHIATRY (2017)
The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner
Bin-Xiao Su et al.
BRAIN RESEARCH (2017)
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP
Juan M. Viveros-Paredes et al.
PHARMACEUTICALS (2017)
Constriction of the buccal branch of the facial nerve produces unilateral craniofacial allodynia
Susannah S. Lewis et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Cognitive behavioral therapy for psychosomatic problems in dental settings
Hirofumi Matsuoka et al.
BIOPSYCHOSOCIAL MEDICINE (2017)
Advances in the Physiology of GPR55 in the Central Nervous System
Bruno A. Marichal-Cancino et al.
CURRENT NEUROPHARMACOLOGY (2017)
Relationships between oral MUC1 expression and salivary hormones in burning mouth syndrome
Jeong-Hyun Kang et al.
ARCHIVES OF ORAL BIOLOGY (2017)
Comparison of Salivary Cortisol and α-amylase Levels and Psychological Profiles in Patients with Burning Mouth Syndrome
Tahereh Nosratzehi et al.
SPECIAL CARE IN DENTISTRY (2017)
Individual oral symptoms in burning mouth syndrome may be associated differentially with depression and anxiety
Simon J. C. Davies et al.
ACTA ODONTOLOGICA SCANDINAVICA (2016)
Characteristic changes of saliva and taste in burning mouth syndrome patients
Hiroko Imura et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
Effect of a 2% topical chamomile application for treating burning mouth syndrome: a controlled clinical trial
Sara Valenzuela et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
Neurobiological Interactions Between Stress and the Endocannabinoid System
Maria Morena et al.
NEUROPSYCHOPHARMACOLOGY (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
The Efficacy of Daily Prefrontal Repetitive Transcranial Magnetic Stimulation (rTMS) for Burning Mouth Syndrome (BMS): A Randomized Controlled Single-blind Study
Yojiro Umezaki et al.
BRAIN STIMULATION (2016)
Grey matter changes of the pain matrix in patients with burning mouth syndrome
Charlotte Sinding et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Cannabinoids, inflammation, and fibrosis
Robert B. Zurier et al.
FASEB JOURNAL (2016)
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
Marco Colizzi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Peripheral nervous system involvement in primary burning mouth syndromeresults of a pilot study
A. Puhakka et al.
ORAL DISEASES (2016)
Impact of reassurance on pain perception in patients with primary burning mouth syndrome
V. Brailo et al.
ORAL DISEASES (2016)
Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome
C. Treldal et al.
ORAL DISEASES (2016)
Nabilone for the Management of Pain
Corey C. Tsang et al.
PHARMACOTHERAPY (2016)
The Detection of Small-Fiber Neuropathies in Burning Mouth Syndrome and latrogenic Lingual Nerve Injuries: Use of Quantitative Sensory Testing
Zehra Yilmaz et al.
JOURNAL OF ORAL & FACIAL PAIN AND HEADACHE (2016)
The relationship between the clinical features of idiopathic burning mouth syndrome and self-perceived quality of life
Adeline Braud et al.
JOURNAL OF ORAL SCIENCE (2016)
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis
Alberto Gajofatto
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
The prevalence of burning mouth syndrome: a population-based study
J. J. Kohorst et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
A. Feliu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Effect of Circadian Rhythm on Clinical and Pathophysiological Conditions and Inflammation
Takako Kizaki et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2015)
Peripheral Neuropathic Facial/Trigeminal Pain and RANTES/CCL5 in Jawbone Cavitation
Johann Lechner et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Alice in Wonderland Syndrome, Burning Mouth Syndrome, Cold Stimulus Headache, and HaNDL: Narrative Review
Marcelo M. Valenca et al.
HEADACHE (2015)
Correlation of Toll-Like Receptor 4, Interleukin-18, Transaminases, and Uric Acid in Patients With Chronic Periodontitis and Healthy Adults
Shaheena Banu et al.
JOURNAL OF PERIODONTOLOGY (2015)
Temperament and character profiles of patients with burning mouth syndrome
Tatsuya Tokura et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2015)
Endocannabinoid signalling and the deteriorating brain
Vincenzo Di Marzo et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Low regional cerebral blood flow in burning mouth syndrome patients with depression
B-L Liu et al.
ORAL DISEASES (2015)
Pathophysiology of primary burning mouth syndrome with special focus on taste dysfunction: a review
M. Kolkka-Palomaa et al.
ORAL DISEASES (2015)
The nocebo effect might affect treatment expectations in patients with burning mouth syndrome
Elena Maria Varoni et al.
PAIN (2015)
Involvement of peripheral artemin signaling in tongue pain: possible mechanism in burning mouth syndrome
Masamichi Shinoda et al.
PAIN (2015)
The Relationship Between Sociodemographic Characteristics and Clinical Features in Burning Mouth Syndrome
Daniela Adamo et al.
PAIN MEDICINE (2015)
The effectiveness of acupuncture versus clonazepam in patients with burning mouth syndrome
A. Jurisic Kvesic et al.
ACUPUNCTURE IN MEDICINE (2015)
Circadian rhythms variation of pain in burning mouth syndrome
Pia Lopez-Jornet et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2015)
Assessment of self-reported sleep disturbance and psychological status in patients with burning mouth syndrome
P. Lopez-Jornet et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
The Association of Openness Personality Trait with Stress-Related Salivary Biomarkers in Burning Mouth Syndrome
Fabricio T. A. de Souza et al.
NEUROIMMUNOMODULATION (2015)
Endocannabinoids in Synaptic Plasticity and Neuroprotection
Jian-Yi Xu et al.
NEUROSCIENTIST (2015)
Evaluation of salivary function in patients with burning mouth syndrome
Y. C. Lee et al.
ORAL DISEASES (2015)
Immune and Endocrine Function in Patients With Burning Mouth Syndrome
Kazuyoshi Koike et al.
CLINICAL JOURNAL OF PAIN (2014)
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
M. Serpell et al.
EUROPEAN JOURNAL OF PAIN (2014)
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue
Patrick McDonough et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Duloxetine in the treatment of burning mouth syndrome refractory to conventional treatment: A case report
Yeon-Dong Kim et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2014)
A Population-Based Study of the Incidence of Burning Mouth Syndrome
John J. Kohorst et al.
MAYO CLINIC PROCEEDINGS (2014)
Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation
Satu K. Jaaskelainen et al.
PAIN (2014)
Altered structure and function in the hippocampus and medial prefrontal cortex in patients with burning mouth syndrome
Shariq A. Khan et al.
PAIN (2014)
Functional and biochemical interaction between PPARα receptors and TRPV1 channels: Potential role in PPARα agonists-mediated analgesia
Paolo Ambrosino et al.
PHARMACOLOGICAL RESEARCH (2014)
Control of synaptic function by endocannabinoid-mediated retrograde signaling
Masanobu Kano
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2014)
A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray
C. G. Stott et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
Irene Paterniti et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy
Sonja Pezelj-Ribaric et al.
LASERS IN MEDICAL SCIENCE (2013)
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
Matthew N. Hill et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
Yang Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects
Eva de Lago et al.
NEUROPHARMACOLOGY (2012)
Sweet taste and chorda tympani transection alter capsaicin-induced lingual pain perception in adult human subjects
N. Schoebel et al.
PHYSIOLOGY & BEHAVIOR (2012)
Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome
H-Il Kim et al.
ORAL DISEASES (2012)
Identification of the Synthetic Cannabinoid R(+) WIN55,212-2 as a Novel Regulator of IFN Regulatory Factor 3 Activation and IFN-β Expression RELEVANCE TO THERAPEUTIC EFFECTS IN MODELS OF MULTIPLE SCLEROSIS
Eric J. Downer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome
P. Lopez-Jornet et al.
ORAL DISEASES (2011)
Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain
Tero Taiminen et al.
SCANDINAVIAN JOURNAL OF PAIN (2011)
Sensory purinergic receptor P2X3 is elevated in burning mouth syndrome
Kiran Beneng et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2010)
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors
A. Castillo et al.
NEUROBIOLOGY OF DISEASE (2010)
Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study
V. Borelli et al.
ORAL DISEASES (2010)
Effect of lingual nerve block on burning mouth syndrome (stomatodynia): A randomized crossover trial
Christelle Gremeau-Richard et al.
PAIN (2010)
Salivary and serum levels of substance P, neurokinin A and calcitonin gene related peptide in burning mouth syndrome
Vanja-Vucicevic Boras et al.
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL (2010)
Salivary levels of IL-1 beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome
Kyung-Im Suh et al.
ARCHIVES OF ORAL BIOLOGY (2009)
Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome
Jasna Zidverc-Trajkovic et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2009)
Palliative effect of lafutidine on oral burning sensation
M. Toida et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2009)
Group psychotherapy: An additional approach to burning mouth syndrome
Ivan Dieb Miziara et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2009)
Burning mouth syndrome: the role of contact hypersensitivity
R. Marino et al.
ORAL DISEASES (2009)
Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case-control study
Carolina Sommer Dias Fernandes et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2009)
Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans
Deepak Cyril D'Souza et al.
PSYCHOPHARMACOLOGY (2009)
Role of central dopamine in pain and analgesia
Patrick B Wood
Expert Review of Neurotherapeutics (2008)
Serum cytokine and T regulatory cell levels in patients with burning mouth syndrome
Filiz Namdar Pekiner et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2008)
Anxiety and salivary cortisol levels in patients with burning mouth syndrome:: case-control study
Jose Miguel Amenabar et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2008)
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
G. Esposito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin. receptor TRPV1 in nerve fibres correlates with pain score
Z. Yilmaz et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2007)
Serum interleukin-6 in patients with burning mouth syndrome and relationship with depression and perceived pain
Qianming Chen et al.
MEDIATORS OF INFLAMMATION (2007)
Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways
Anne Wisner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
From Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants
Norman Pecoraro et al.
PROGRESS IN NEUROBIOLOGY (2006)
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
Giuseppe Esposito et al.
NEUROSCIENCE LETTERS (2006)
Salivary interleukin-6 and tumor necrosis factor-α in patients with burning mouth syndrome
V. Vucicevic Boras et al.
ORAL DISEASES (2006)
Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments
A Sardella et al.
ORAL DISEASES (2006)
Cannabinoid signalling
DG Demuth et al.
LIFE SCIENCES (2006)
Detection of salivary interleukin 2 and interleukin 6 in patients with burning mouth syndrome
Daria Simcic et al.
MEDIATORS OF INFLAMMATION (2006)
Interleukin-1 beta and serotonin transporter gene polymorphisms in burning mouth syndrome patients
Andre Luiz Sena Guimaraes et al.
JOURNAL OF PAIN (2006)
Cerebral activation during thermal stimulation of patients who have burning mouth disorder: An fMRI study
Romulo J. C. Albuquerque et al.
PAIN (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
Jared Ehrhart et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
WS Sheng et al.
GLIA (2005)
Vulnerability and presenting symptoms in burning mouth syndrome
PJ Lamey et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2005)
Taste damage: Previously unsuspected consequences
LM Bartoshuk et al.
CHEMICAL SENSES (2005)
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells
T Iuvone et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Evidence of augmented central pain processing in idiopathic chronic low back pain
T Giesecke et al.
ARTHRITIS AND RHEUMATISM (2004)
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
C Vaney et al.
MULTIPLE SCLEROSIS (2004)
Gonadectomy induces site-specific differences in nociception in rats
J Pajot et al.
PAIN (2003)
Striatal dopamine D1 and D2 receptors in burning mouth syndrome
N Hagelberg et al.
PAIN (2003)
Therapeutic potential of cannabinoids in CNS disease
JL Croxford
CNS DRUGS (2003)
The physiology, medical management and oral implications of menopause
AH Friedlander
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2002)
Oral symptoms at menopause - the role of hormone replacement therapy
L Tarkkila et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2001)
Oral mucosal blood flow in patients with burning mouth syndrome
SM Heckmann et al.
PAIN (2001)
Δ9-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells -: Involvement of CB1 cannabinoid receptor and Raf-1
L Velasco et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
分享论文
